M&G Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

M&G Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$366M	Buy	7,186,037 +903,235	+14%	+$47.4M	1.3%	8
2023 Q3	$364M	Buy	6,282,802 +383,857	+7%	+$23.5M	1.63%	6
2023 Q2	$378M	Buy	5,898,945 +924,315	+19%	+$62M	1.51%	7
2023 Q1	$343M	Buy	4,974,630 +597,422	+14%	+$42.1M	1.62%	7
2022 Q4	$315M	Buy	4,377,208 +143,348	+3%	+$10.8M	1.56%	7
2022 Q3	$301K	Buy	4,233,860 +116,045	+3%	+$8.42M	1.74%	6
2022 Q2	$317K	Sell	4,117,815 -415,703	-9%	-$31.7M	1.87%	6
2022 Q1	$331K	Sell	4,533,518 -777,289	-15%	-$52.2M	0.65%	8
2021 Q4	$329K	Buy	5,310,807 +838,173	+19%	+$49.2M	0.85%	10
2021 Q3	$264K	Buy	4,472,634 +128,254	+3%	+$8.45M	0.63%	11
2021 Q2	$291K	Sell	4,344,380 -383,396	-8%	-$25M	0.72%	9
2021 Q1	$298K	Sell	4,727,776 -330,648	-7%	-$20.6M	0.94%	6
2020 Q4	$314K	Sell	5,058,424 -4,331	-0.1%	-$266K	1.95%	8
2020 Q3	$304M	Sell	5,062,755 -796,024	-14%	-$47.9M	3.03%	3
2020 Q2	$346M	Buy	5,858,779 +448,524	+8%	+$26.8M	3.66%	2
2020 Q1	$303M	Sell	5,410,255 -139,859	-3%	-$8.55M	3.68%	3
2019 Q4	$355M	Buy	+5,550,114	New	+$318M	3.14%	3

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

M&G Investment Management's BMY Position: Q4 2023 in Review

M&G Investment Management increased its Bristol-Myers Squibb (BMY) stake by 14% in Q4 2023, buying an estimated $47.4M and bringing the position to 7,186,037 shares worth $366M. The position accounts for 1.3% of the portfolio, ranked #8.

M&G Investment Management first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $378M in Q2 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

M&G Investment Management held 7,186,037 shares of Bristol-Myers Squibb worth $366M as of Q4 2023.
M&G Investment Management bought 903,235 Bristol-Myers Squibb shares in Q4 2023, an estimated $47.4M.
Bristol-Myers Squibb made up 1.3% of M&G Investment Management's portfolio in Q4 2023, its #8 holding.
M&G Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
M&G Investment Management's Bristol-Myers Squibb position peaked at $378M in Q2 2023.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.